ResearchMoz

Dyslexia Global Clinical Trials Review, H1, 2013

GlobalData
Published Date » 2013-04-12
No. Of Pages » 59
 Dyslexia Global Clinical Trials Review, H1, 2013  Summary   GlobalData's clinical trial report, Dyslexia Global Clinical Trials Review, H1, 2013" provides data on the Dyslexia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Dyslexia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. 
   
 The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Dyslexia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house...
Table of Content

Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Dyslexia 5
Symptoms of dyslexia are: 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by BRIC Nations 13
Clinical Trials by G7 Nations 14
Clinical Trials in G7 Nations by Trial Status 15
Clinical Trials by E7 Nations 16
Clinical Trials in E7 Nations by Trial Status 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Unaccomplished Trials of Dyslexia 21
Subjects Recruited Over a Period of Time 22
Prominent Sponsors 23
Prominent Drug Comparison 25
Clinical Trial Profiles 26
Clinical Trial Overview of Top Companies 26
Eli Lilly and Company 26
Clinical Trial Overview of Eli Lilly and Company 26
Clinical Trial Overview of Top Universities / Institutes / Hospitals 27
University Hospital, Tours 27
Clinical Trial Overview of University Hospital, Tours 27
Macquarie University 28
Clinical Trial Overview of Macquarie University 28
University of Tasmania 29
Clinical Trial Overview of University of Tasmania 29
University of Munster 30
Clinical Trial Overview of University of Munster 30
McGill University 31
Clinical Trial Overview of McGill University 31
University of Oxford 32
Clinical Trial Overview of University of Oxford 32
Vanderbilt University 33
Clinical Trial Overview of Vanderbilt University 33
Rabin Medical Center 34
Clinical Trial Overview of Rabin Medical Center 34
Five Key Clinical Profiles 35

Appendix 57
Abbreviations 57
Definitions 57
Research Methodology 58
Secondary Research 58
About GlobalData 59
Contact Us 59
Disclaimer 59
Source 59

List of Tables


Dyslexia Therapeutics Market, Global, Clinical Trials by Zone, 2013* 6
Dyslexia Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 7
Dyslexia Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 8
Dyslexia Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2013* 9
Dyslexia Therapeutics Clinical Trials, Europe, Top Countries, 2013* 10
Dyslexia Therapeutics Clinical Trials, North America, Top Countries, 2013* 11
Dyslexia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2013* 12
Dyslexia Therapeutics Clinical Trials, BRIC Countries, 2013* 13
Dyslexia Therapeutics Clinical Trials, G7 Countries, 2013* 14
Dyslexia Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 15
Dyslexia Therapeutics Clinical Trials, E7 Countries, 2013* 16
Dyslexia Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 17
Dyslexia Therapeutics Market, Global, Clinical Trials by Phase, 2013* 18
Dyslexia Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 19
Dyslexia Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 20
Dyslexia Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 21
Dyslexia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 22
Dyslexia Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 24
Dyslexia Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 25
Dyslexia Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2013* 26
Dyslexia Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Tours, 2013* 27
Dyslexia Therapeutics Clinical Trials Market, Global, Clinical Trials by Macquarie University, 2013* 28
Dyslexia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Tasmania, 2013* 29
Dyslexia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Munster, 2013* 30
Dyslexia Therapeutics Clinical Trials Market, Global, Clinical Trials by McGill University, 2013* 31
Dyslexia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2013* 32
Dyslexia Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2013* 33
Dyslexia Therapeutics Clinical Trials Market, Global, Clinical Trials by Rabin Medical Center, 2013* 34

List of Figures


Dyslexia Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 6
Dyslexia Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 7
Dyslexia Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 8
Dyslexia Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2013* 9
Dyslexia Therapeutics Clinical Trials, Europe, Top Countries (%), 2013* 10
Dyslexia Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 11
Dyslexia Therapeutics Clinical Trials, G7 Countries (%), 2013* 14
Dyslexia Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 15
Dyslexia Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 18
Dyslexia Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 19
Dyslexia Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 20
Dyslexia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 22
Dyslexia Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 23
Dyslexia Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 25
GlobalData Methodology 58

Upcoming Reports:

Diabetic Macular Edema Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
By - Transparency Market Research
Macular edema is the condition when the fluid and proteins start collecting on or under the macula of the eye thereby resulting in swelling.  Due to such swelling, a person’s central eye vision gets distorted. Macular edema is classified into two types namely cystoids macular edema (CME) and diabetic macular edema (DME). Diabetic macular edema is the major reason for loss of vision in patients suffering from diabetic retinopathy. Diabetes patient are reported to have a 10% risk of developing this condition during their lifetime. On the basis of the cause of disease, DME...
Generic Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018
By - Transparency Market Research
The generic drugs industry comprises of the manufacture and marketing of certain drugs which have the same active ingredients as the brand-name drugs manufactured by any pharmaceutical company. The major benefit of generic drugs is that the cost of such drugs is much less than that of branded drugs. Generic drugs come under the same governing framework as that of the brand-name drugs. The rationale behind generic drugs is that the patented drugs generally have a patent life of 20 years. However, the patent life of such drugs begins from the clinical trials and thus their commercial...
Machine To Machine Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018
By - Transparency Market Research
Machine to Machine also known as M2M, is a cumulating set of technologies which combines both wireless and wired network systems for communicating with other devices. The basic components of M2M systems are a sensory device which grabs signals and transmits them further to a network which could be both wireless as well as wired; an application software to process such data and finally into a relevant information. Certain major machine to machine technologies which are currently in vogue are 2G and 3G technologies, Wireless Fidelity (WiFi), Ethernet, ZigBee etc. Machine to...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

A Health Tech Incubator Started by GE Healthcare
Oct 30, 2014  
For the very first time, a health tech start up campus has been established by GE Healthcare at its headquarters at Helsinki, Finland. This area already has about twenty such healthcare start ups that are working on cloud services, wireless technologies, apps, and sensors that aim at improving healthcare. The main rationale behind such a step is providing opportunities for further...
Net Earnings of DuPont Increases 52% despite Agricultural Turmoil
Oct 29, 2014  
DuPont - The Wilmington, Del-based leading chemical company faced decline of three percent sales to $7.5 billion in the quarter ending of September 30. The company’s third-quarter earnings were increased by 52 percent to $433 million albeit the slow global growth and agricultural downside.   The company witnessed the biggest drags from chemical sales with eight percent...
Appeal for Sanitization in Construction Industry through Government Regulations: CIOB Ghana
Oct 29, 2014  
Rockson Dogbegah - The Chairman of the Chartered Institute of Building Ghana commented that the construction industry needs a thorough cleaning up and assurance of proper growth. Mr. Dogbegah also said that a few factors are extremely important for a proper development in the construction industry. These include keen adherence to standards, supreme sense of professionalism, and sheer pursuance...
Facebook Hints of Rise in Expenses in 2015, Shares Drop
Oct 29, 2014  
Facebook has announced on Tuesday that it is prepping for a dramatic rise in spending in the year 2015. This warning has come combined with a projected slowdown in the company’s revenues after revenues were analyzed at the end of the third quarter of the year. The plans of such hefty spending in the next financial year by the company are indicative of stress in the investor...
Samsung Records Poorest Profits in Q3 2014
Oct 29, 2014  
In the quarter ending September 2014, Samsung Electronics Co. Ltd registered the smallest earnings ever in two years. The drop in earnings can be easily attributed to heavy competition from new Chinese devices and the Apple phones. The net income stood at US$4 billion for the South Korea-based company. Apple has been Samsung’s strongest contender ever since the latter entered the...